Harnessing the potential of a novel immune checkpoint Invectys exploits a powerful immune checkpoint (ICP) named HLA-G. It is found mostly at the fetal-maternal…
Using specific cancer markers to turn “cold” tumors “hot” Cells will express on their surface short protein fragments – peptides – corresponding to proteins…
A DNA vaccine targeting a specific cancer marker Cancer cells produce an enzyme which is key to their unlimited proliferation, but is nearly never expressed in normal…
Invectys develops a full range of innovative and very promising immunotherapeutic oncology products for human health: INVAC-1: DNA-based vaccine expressing an inactivated…
